ArticleOpen research Europe2025
Dimensions, stability, and deformability of DOPC-cholesterol giant unilamellar vesicles formed by droplet transfer.
Article in Open research Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dimensions, stability, and deformability of DOPC-cholesterol giant unilamellar vesicles formed by droplet transfer.Open research Europe · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Understanding cell membrane-like lipid bilayers is crucial for studying fundamental biological mechanisms. Giant Unilamellar Vesicles (GUVs) are key tools for this investigation and have applications in both synthetic biology and, more recently, in microrobotics. The effects of cholesterol, a key component of cellular membranes, on synthetic phospholipid membrane models like GUVs are however not fully understood, as they may vary with lipid composition and production method. Methods: We examined the size distribution, temporal stability and deformability of GUVs prepared with the droplet transfer method using different Dioleoylphosphatidylcholine (DOPC) to cholesterol ratios in the oil phase (namely 100:0, 85:15, 71:29, 60:40). Phase-contrast microscopy assessed size and stability, while deformability was tested by loading the GUVs with an aqueous ferrofluid and applying a uniform magnetic field to induce their elongation. Image analysis was conducted using Fiji and a custom Julia script. Results: The median diameters increased with the content of cholesterol, together with the dimensional distribution. In terms of stability, cholesterol generally reduced GUV median diameter over time, while it varyingly influenced the number of vesicles. As for deformability, beyond the expected elongation dependent on the intensity of the applied magnetic field, there were no statistically significant differences in GUV deformability in the presence or absence of cholesterol. Conclusions: Our findings suggest that cholesterol can lead to increased average diameter of GUVs made with DOPC through droplet transfer, while varyingly affecting their time-stability and not affecting their deformability. This study shows how small adjustments on a straightforward protocol like the droplet transfer method, provide a simple and effective way of tailoring GUV properties. Edits in the oil phase enable precise tuning of GUV membranes providing a tool for both fundamental studies and applications such as artificial cells or microrobots.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.